NCT04144777

Efficacy of Solarplast for Health and Oxidative Stress

Completed NA Last updated 15 February 2021

What this trial tests

NA trial testing Solarplast in Oxidative Stress in 84 participants. Completed in 1 May 2020.

Timeline

15 July 2019

Primary endpoint
1 May 2020

1 May 2020

Quick facts

Lead sponsor	Deerland Enzymes
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	basic science
Enrollment	84
Start date	15 July 2019
Primary completion	1 May 2020
Estimated completion	1 May 2020
Sites	1 location across United States

Drugs / interventions tested

• Solarplast

Conditions studied

• Oxidative Stress — all drugs for Oxidative Stress →
• Healthy Aging — all drugs for Healthy Aging →
• Skin Health — all drugs for Skin Health →

Sponsor

Deerland Enzymes

Who can join

Adults 18 to 65, any sex, with Oxidative Stress or Healthy Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Solarplast is a unique mixture of antioxidant enzymes and single antioxidant molecules that are capable of attack oxidants that cause damage to the cells in the human body and cause premature aging. This mechanism may provide protection from stress, such as free radicals, heat, infection, as well as reduce inflammation and participate in the repair mechanism of the intestinal tract. Participants will consume Solarplast, or placebo, for 45 days with blood draws at day-0 and -45 in order to assess antioxidant capacity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Solarplast^® Demonstrates Anti-Inflammatory and Anti-Oxidant Activity In Vivo and Positively Modulates Perceived Anti-Ageing Quality of Life Questionnaire and Skin Analogue Scale.
   Rea K, Inarejos-Garcia AM, Guilera Bermell S, Garcia Bou R, et al · · 2024 · PMID 39684397 · DOI 10.3390/ijms252312689